News Releases

Month Year

Email Alerts

Jul 10, 2008

Insmed Announces First Human Bioequivalence Data for a Follow-on Biologic by a U.S. Company
Jul 9, 2008

Insmed to Present at Collins Stewart Fourth Annual Growth Conference
Jun 20, 2008

Insmed to Request Hearing Before NASDAQ Panel to Review NASDAQ Staff Determination
May 8, 2008

Insmed Announces First Quarter 2008 Financial Results
May 8, 2008

/C O R R E C T I O N -- Insmed Inc./
Apr 29, 2008

Insmed Provides Update on Follow-On Biologics and IPLEX(TM) Programs
Apr 24, 2008

Insmed to Host First Quarter 2008 Conference Call
Apr 22, 2008

Insmed to Present at CBI Follow-On Biologics Conference
Apr 16, 2008

Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R)
Apr 10, 2008

Insmed Selected to Complete Congressional Questionnaire Regarding the Potential Establishment of a Follow-On Biologics Regulatory Pathway
Mar 8, 2008

Insmed Announces Additional Information in Compliance With NASDAQ Rules
Mar 4, 2008

Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results
Feb 28, 2008

Insmed Announces Listing Transfer from Nasdaq Global Market to Nasdaq Capital Market
Feb 19, 2008

Insmed to Host Fourth Quarter and Full-Year 2007 Conference Call
Feb 11, 2008

Study by Leading Economist Identifies Potential for $378 Billion of Savings From Follow On Biologics
Feb 5, 2008

Insmed Launches National Awareness Campaign Surrounding Follow-On Biologics
Feb 5, 2008

Insmed CEO Issues Statement on White House FY09 Budget and FDA Statements on Follow-On Biologics
Jan 28, 2008

Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis
Jan 22, 2008

Insmed Completes External Assessment of Myotonic Muscular Dystrophy Market
Dec 18, 2007

Insmed Receives FDA Orphan Drug Designation for IPLEX(TM) in the Treatment of Myotonic Muscular Dystrophy
Dec 12, 2007

Insmed Awarded $2.1 Million by Muscular Dystrophy Association
Dec 6, 2007

Insmed to Present at the IBC 5th Annual Global Follow-On Biologics Conference
Dec 6, 2007

Insmed Appoints Dennis M. Lanfear to Board Of Directors
Dec 3, 2007

Insmed Retains FD and Gibraltar Associates for Investor Relations and Corporate Communications
Nov 13, 2007

Insmed Advances Follow on Biologics Initiative

Show per page

Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your
email alerts.

View the latest Insmed Investor Presentation

Download

Our Global Company

Current Clinical Trials

Our Research Team

Our Global Company

Current Clinical Trials

Our Research Team

Footer